NorthWest Biotherapeutics Inc (NWBO)

[gnawkz]

I second the preparation for limited PPS movement in 2015.

From all of the events that have occurred in 2014 (or lack thereof), it is important to note the NWBO is swimming in uncharted waters:
- No hard information on HE reimbursement due to complexity of contract negotiations with multiple parties (6 contracts per hospital for 10 hospitals)
- Extension of –L trial due to BSSR and long path of regulatory approval from 3 different agencies
- Continuous manufacturing improvements
- (I am fairly certain others will be able to continue to add to this list) …

It is prudent to invest appropriately and have reasonable expectations. Personally, my expectation is significant PPS movement in 2016 with 2017 onwards being the major growth years. I am hopeful for a massive increase in 2015, but if it doesn’t happen I will not be worried.